MacroGenics Profit Margin 2012-2018 | MGNX
Current and historical gross margin, operating margin and net profit margin for MacroGenics (MGNX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. MacroGenics net profit margin as of December 31, 2018 is -285.18%.
|MacroGenics Annual Profit Margins
|MacroGenics Quarterly Profit Margins
||Medical Products Manufacturing
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.